For the past 60 years during intense research on the causes and treatments for cancer --- the focus has been on finding “The Magic Bullet.” Theory after theory has come and gone. Each has produced its own crop of “cures”, and each, in turn, has quietly slipped into oblivion as it was proven yet again to be another blind alley. Alpha-Interferon, Gleevec, MTX and others, took their turns on the covers of Newsweek or Time, proclaiming to be THE magic bullet that was going to bring an end to the scourge of cancer. And each, in turn, has failed; --but not completely.

The common defect of these approaches --and most current efforts-- is that each takes a compartmentalized view. They try and separate the patient’s cancer from the patient, --they see the immune system as separate from their endocrine system --- the drugs and the drug effects separate from the patient's nutritional status, etc.. THAT’S what has failed .

Based on our Research and experience, our approach is to integrate rather than segregate ---to complement rather than isolate. Taking this broader view requires the assessment of a wide range of patient factors; including immunodiagnostics, immunohistochemistry and cytopathology. MRL's algorithm integrates this data, and much more, to produce an individualized set of recommended treatment protocols, using a blend of allopathic, biologic, naturopathic, and nutritional techniques that support the patient’s biochemistry and reconstitutes their immune system. Life style, attitude and emotional state also play a critical role.
The prescribed treatments are immunologically-based and thus, significantly less toxic and, in the long run, much less expensive than protocols currently in use.